PULM
Price:
$1.4
Market Cap:
$5.11M
Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform allows for the precise delivery of both small and large molecule therapeutics directly into the lungs, achieving either localized effects or systemic distribution throughout the body. Pulmatrix's development pipeline includes several key candidates: Pulmazole: An inhaled antifungal drug being developed t...[Read more]
Industry
Biotechnology
IPO Date
2014-03-21
Stock Exchange
NASDAQ
Ticker
PULM
According to Pulmatrix, Inc.’s latest financial reports and current stock price. The company's current ROE is -102.06%. This represents a change of 295.73% compared to the average of -25.79% of the last 4 quarters.
The mean historical ROE of Pulmatrix, Inc. over the last ten years is -136.38%. The current -102.06% ROE has changed -25.16% with respect to the historical average. Over the past ten years (40 quarters), PULM's ROE was at its highest in in the March 2024 quarter at 4.34%. The ROE was at its lowest in in the December 2016 quarter at -112.20%.
Average
-136.38%
Median
-121.16%
Minimum
-317.81%
Maximum
-42.51%
Discovering the peaks and valleys of Pulmatrix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 296.01%
Maximum Annual ROE = -42.51%
Minimum Annual Increase = -55.36%
Minimum Annual ROE = -317.81%
| Year | ROE | Change |
|---|---|---|
| 2025 | -135.49% | 26.81% |
| 2024 | -106.84% | 36.15% |
| 2023 | -78.47% | 29.60% |
| 2022 | -60.55% | 42.43% |
| 2021 | -42.51% | -49.05% |
| 2020 | -83.44% | -55.36% |
| 2019 | -186.91% | 7.66% |
| 2018 | -173.62% | -2.53% |
| 2017 | -178.12% | -43.95% |
| 2016 | -317.81% | 296.01% |
The current ROE of Pulmatrix, Inc. (PULM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-106.93%
5-year avg
-84.77%
10-year avg
-136.38%
Pulmatrix, Inc.’s ROE is less than Daré Bioscience, Inc. (763.44%), greater than Leap Therapeutics, Inc. (-46.86%), greater than Hoth Therapeutics, Inc. (-165.25%), less than Aspire Biopharma Holdings, Inc. (199.43%), greater than Palisade Bio, Inc. (-36.79%), less than Aditxt, Inc. (926.02%), less than Curis, Inc. (805.67%), greater than FibroBiologics, Inc. Common Stock (-767.07%), greater than Longeveron Inc. (-202.41%), greater than Citius Pharmaceuticals, Inc. (-67.42%),
| Company | ROE | Market cap |
|---|---|---|
| 763.44% | $19.23M | |
| -46.86% | $31.86M | |
| -165.25% | $14.92M | |
| 199.43% | $572.25K | |
| -36.79% | $296.82M | |
| 926.02% | $425.00 | |
| 805.67% | $5.55M | |
| -767.07% | $1.95M | |
| -202.41% | $15.60M | |
| -67.42% | $6.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmatrix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pulmatrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pulmatrix, Inc.'s ROE?
How is the ROE calculated for Pulmatrix, Inc. (PULM)?
What is the highest ROE for Pulmatrix, Inc. (PULM)?
What is the 3-year average ROE for Pulmatrix, Inc. (PULM)?
What is the 5-year average ROE for Pulmatrix, Inc. (PULM)?
How does the current ROE for Pulmatrix, Inc. (PULM) compare to its historical average?